Trypanosoma cruzi: In vitro Morphological Alterations Induced by Actinomycin D
Authors:
- Tânia Zaverucha Do ValleTVTânia Zaverucha Do Valle
- Kátia S. CalabreseKCKátia S. Calabrese
- Suzana Côrte-RealSCSuzana Côrte-Real
- Wagner C. BaetasWBWagner C. Baetas
- Sylvio C. Gonçalves da CostaSCSylvio C. Gonçalves da Costa
- 13 January 2003
- journal article
- research article
- Published by S. Karger AG in Pharmacology
- Vol. 67 (2) , 55-58
Abstract
Actinomycin (ActD) is an antibiotic that binds DNA, preventing transcription. When a Trypanosoma cruzi infection in mice is treated with this drug, the parasite loses its ability to multiply, enabling protection. In this study, axenic cultured T. cruzi parasites were exposed to different concentrations of ActD (10, 20, and 50 µg/ml), all of them being able to inhibit growth and to alter the mobility. Nevertheless, the parasites remained alive and motile for at least 14 days. Scanning electron microscopy of trypomastigotes treated with 10 µg/ml of ActD for 24 h showed a modification in their morphology which suggests a change in the parasite cytoskeleton.Keywords
This publication has 3 references indexed in Scilit:
- Crucial importance of PKC-β(I) in LFA-1–mediated locomotion of activated T cellsNature Immunology, 2001
- A motility function for the paraflagellar rod of Leishmania parasites revealed by PFR-2 gene knockoutsMolecular and Biochemical Parasitology, 1997
- The paraflagellar rod of kinetoplastida: Solved and unsolved questionsParasitology Today, 1996